National Institute of Allergy and Infectious Diseases; Notice of Closed Meeting, 61767-61768 [2017-28156]
Download as PDF
<![CDATA[
Federal Register / Vol. 82, No. 249 / Friday, December 29, 2017 / Notices
Time: 8:00 a.m. to 3:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: JW Marriott New Orleans, 614 Canal
Street, New Orleans, LA 70130.
Contact Person: Birgit Neuhuber, Ph.D.,
Scientific Review Officer, Scientific Review
Branch, NINDS/NIH/DHHS, Neuroscience
Center, 6001 Executive Blvd., Suite 3204,
MSC 9529, Bethesda, MD 20892–9529,
neuhuber@ninds.nih.gov.
Name of Committee: National Institutes of
Neurological Disorders and Stroke, Special
Emphasis Panel, NSD Member Conflict SEP.
Date: February 22, 2018.
Time: 4:00 p.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: JW Marriott New Orleans, 614 Canal
Street, New Orleans, LA 70130.
Contact Person: Birgit Neuhuber, Ph.D.,
Scientific Review Officer, Scientific Review
Branch, NINDS/NIH/DHHS, Neuroscience
Center, 6001 Executive Blvd., Suite 3204,
MSC 9529, Bethesda, MD 20892–9529,
neuhuber@ninds.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.853, Clinical Research
Related to Neurological Disorders; 93.854,
Biological Basis Research in the
Neurosciences, National Institutes of Health,
HHS)
Dated: December 22, 2017.
Sylvia L. Neal,
Program Analyst, Office of Federal Advisory
Committee Policy.
Dated: December 22, 2017.
Sylvia L. Neal,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2017–28155 Filed 12–28–17; 8:45 am]
[FR Doc. 2017–28157 Filed 12–28–17; 8:45 am]
BILLING CODE 4140–01–P
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institutes of Health
National Institute of Neurological
Disorders and Stroke; Notice of Closed
Meetings
ethrower on DSK3G9T082PROD with NOTICES
Place: National Institutes of Health, 5601
Fishers Lane, Rockville, MD 20892
(Telephone Conference Call).
Contact Person: Robert C. Unfer, Ph.D.,
Scientific Review Officer, Scientific Review
Program, DEA/NIAID/NIH/DHHS, 5601
Fishers Lane, Room 3F40 MSC 9823,
Rockville, MD 20892–9823, 240–669–5035,
unferrc@nih.gov.
Name of Committee: National Institute of
Allergy and Infectious Diseases Special
Emphasis Panel; PHS 2018–1 Topic 54 & 55:
Adjuvant Discovery & Development for
Autoimmune Diseases.
Date: January 31, 2018.
Time: 11:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate contract
proposals.
Place: National Institutes of Health, 5601
Fishers Lane, Rockville, MD 20892
(Telephone Conference Call).
Contact Person: Dharmendar Rathore,
Ph.D., Scientific Review Officer, Scientific
Review Program, Division of Extramural
Activities, Room 3G30, National Institutes of
Health/NIAID, 5601 Fishers Lane, Drive,
MSC 9823, Bethesda, MD 20892–9823, 240–
669–5058, rathored@mail.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.855, Allergy, Immunology,
and Transplantation Research; 93.856,
Microbiology and Infectious Diseases
Research, National Institutes of Health, HHS)
National Institute on Aging; Notice of
Closed Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Neurological Disorders and Stroke, Initial
Review Group, Neurological Sciences and
Disorders B.
Date: February 22, 2018.
VerDate Sep<11>2014
20:09 Dec 28, 2017
Jkt 244001
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute on
Aging Initial Review Group; Behavior and
Social Science of Aging Review Committee
NIA–S.
Date: February 1–2, 2018.
Time: 10:00 a.m. to 3:00 p.m.
PO 00000
Frm 00040
Fmt 4703
Sfmt 4703
61767
Agenda: To review and evaluate grant
applications.
Place: Bethesda North Marriott Hotel &
Conference Center, 5701 Marinelli Road,
Bethesda, MD 20852.
Contact Person: Kimberly Firth, Ph.D.,
National Institute on Aging, Gateway
Building, 7201 Wisconsin Avenue, Suite
2C212, Bethesda, MD 20892, 301–402–7702,
kimberly.firth@nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.866, Aging Research,
National Institutes of Health, HHS)
Dated: December 26, 2017.
David Clary,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2017–28154 Filed 12–28–17; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Allergy and
Infectious Diseases; Notice of Closed
Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The contract proposals and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the contract
proposals, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Allergy and Infectious Diseases Special
Emphasis Panel; PHS 2018–1 Topic 55:
Adjuvant Development for Viral Diseases
Vaccines.
Date: January 26, 2018.
Time: 11:00 a.m. to 4:00 p.m.
Agenda: To review and evaluate contract
proposals.
Place: National Institutes of Health, 5601
Fishers Lane, Rockville, MD 20892
(Telephone Conference Call).
Contact Person: Dharmendar Rathore,
Ph.D., Scientific Review Officer, Scientific
Review Program, Division of Extramural
Activities, Room 3G30, National Institutes of
Health/NIAID, 5601 Fishers Lane, Drive,
MSC 9823, Bethesda, MD 20892–9823, 240–
669–5058, rathored@mail.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.855, Allergy, Immunology,
and Transplantation Research; 93.856,
Microbiology and Infectious Diseases
Research, National Institutes of Health, HHS)
E:\FR\FM\29DEN1.SGM
29DEN1
61768
Federal Register / Vol. 82, No. 249 / Friday, December 29, 2017 / Notices
Dated: December 22, 2017.
Sylvia L. Neal,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2017–28156 Filed 12–28–17; 8:45 am]
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Substance Abuse and Mental Health
Services Administration
BILLING CODE 4140–01–P
Center for Substance Abuse
Treatment; Notice of Meeting
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Pursuant to Public Law 92–463,
notice is hereby given that the
Substance Abuse and Mental Health
Services Administration’s (SAMHSA)
Center for Substance Abuse Treatment
(CSAT) National Advisory Council
(NAC) will meet on February 14, 2018,
9:00 a.m.–5:00 p.m. (EDT).
The meeting is open and will include
consideration of minutes from the
SAMHSA CSAT NAC meeting of August
10, 2017, the Director’s Report, a budget
update, discussion on substance use
disorder spending estimates,
discussions with SAMHSA leadership,
and discussions on the opioid epidemic.
The meeting will be held at the
SAMHSA, 5600 Fishers Lane, Pavilion
C, Rockville, MD 20857. Attendance by
the public will be limited to space
available. Interested persons may
present data, information, or views,
orally or in writing, on issues pending
before the Council. Written submissions
should be forwarded to the contact
person on or before February 5, 2018.
Oral presentations from the public will
be scheduled at the conclusion of the
meeting. Individuals interested in
making oral presentations must notify
the contact person on or before February
5, 2018. Five minutes will be allotted for
each presentation as time permits.
The meeting may be accessed via
telephone. To attend on site, obtain the
call-in number and access code, submit
written or brief oral comments, or
request special accommodations for
persons with disabilities, please register
on-line at https://nac.samhsa.gov/
Registration/meetingsRegistration.aspx,
or communicate with the CSAT
National Advisory Council Designated
Federal Officer; Tracy Goss (see contact
information below).
Meeting information and a roster of
Council members may be obtained by
accessing the SAMHSA Committee
website at https://www.samhsa.gov/
about-us/advisory-councils/csatnational-advisory-council or by
contacting the CSAT National Advisory
Council Designated Federal Officer;
Tracy Goss (see contact information
below).
Council Name: SAMHSA’s Center for
Substance Abuse Treatment National
Advisory Council.
Date/Time/Type: February 14, 2018,
9:00 a.m.–5:00 p.m. EDT, OPEN.
National Institutes of Health
National Institute on Aging; Notice of
Closed Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute on
Aging Special Emphasis Panel; Evaluation of
NIA Clinical Trials.
Date: January 25, 2018.
Time: 12:01 p.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institute on Aging,
Gateway Building, Suite 2W200, 7201
Wisconsin Avenue, Bethesda, MD 20892
(Telephone Conference Call).
Contact Person: Maurizio Grimaldi, MD,
Ph.D., Scientific Review Officer, National
Institute on Aging, National Institutes of
Health, 7201 Wisconsin Avenue, Room
2C218, Bethesda, MD 20892, 301–496–9374,
grimaldim2@mail.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.866, Aging Research,
National Institutes of Health, HHS)
Dated: December 26, 2017.
David Clary,
Program Analyst, Office of Federal Advisory
Committee Policy.
ethrower on DSK3G9T082PROD with NOTICES
[FR Doc. 2017–28153 Filed 12–28–17; 8:45 am]
BILLING CODE 4140–01–P
VerDate Sep<11>2014
20:09 Dec 28, 2017
Jkt 244001
PO 00000
Frm 00041
Fmt 4703
Sfmt 4703
Place: SAMHSA, 5600 Fishers Lane,
Rockville, Maryland 20857.
Contact: Tracy Goss, Designated
Federal Officer, CSAT National
Advisory Council, 5600 Fishers Lane,
Rockville, Maryland 20857 (mail),
Telephone: (240) 276–0759, Fax: (240)
276–2252, Email: tracy.goss@
samhsa.hhs.gov.
Dated: December 22, 2017.
Carlos Castillo,
Committee Management Officer, SAMHSA.
[FR Doc. 2017–28107 Filed 12–28–17; 8:45 am]
BILLING CODE 4162–20–P
DEPARTMENT OF HOMELAND
SECURITY
Federal Emergency Management
Agency
[Internal Agency Docket No. FEMA–3391–
EM; Docket ID FEMA–2017–0001]
Puerto Rico; Amendment No. 2 to
Notice of an Emergency Declaration
Federal Emergency
Management Agency, DHS.
AGENCY:
ACTION:
Notice.
This notice amends the notice
of an emergency declaration for the
Commonwealth of Puerto Rico (FEMA–
3391–EM), dated September 18, 2017,
and related determinations.
SUMMARY:
This amendment was issued
December 6, 2017.
DATES:
FOR FURTHER INFORMATION CONTACT:
Dean Webster, Office of Response and
Recovery, Federal Emergency
Management Agency, 500 C Street SW,
Washington, DC 20472, (202) 646–2833.
Notice is
hereby given that the incident period for
this emergency is closed effective
November 15, 2017.
SUPPLEMENTARY INFORMATION:
The following Catalog of Federal Domestic
Assistance Numbers (CFDA) are to be used
for reporting and drawing funds: 97.030,
Community Disaster Loans; 97.031, Cora
Brown Fund; 97.032, Crisis Counseling;
97.033, Disaster Legal Services; 97.034,
Disaster Unemployment Assistance (DUA);
97.046, Fire Management Assistance Grant;
97.048, Disaster Housing Assistance to
Individuals and Households In Presidentially
Declared Disaster Areas; 97.049,
Presidentially Declared Disaster Assistance—
Disaster Housing Operations for Individuals
and Households; 97.050 Presidentially
Declared Disaster Assistance to Individuals
and Households—Other Needs; 97.036,
Disaster Grants—Public Assistance
E:\FR\FM\29DEN1.SGM
29DEN1
]]>Agencies
[Federal Register Volume 82, Number 249 (Friday, December 29, 2017)]
[Notices]
[Pages 61767-61768]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2017-28156]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Institute of Allergy and Infectious Diseases; Notice of
Closed Meeting
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended, notice is hereby given of the following meeting.
The meeting will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The contract proposals and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the contract proposals, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Institute of Allergy and Infectious
Diseases Special Emphasis Panel; PHS 2018-1 Topic 55: Adjuvant
Development for Viral Diseases Vaccines.
Date: January 26, 2018.
Time: 11:00 a.m. to 4:00 p.m.
Agenda: To review and evaluate contract proposals.
Place: National Institutes of Health, 5601 Fishers Lane,
Rockville, MD 20892 (Telephone Conference Call).
Contact Person: Dharmendar Rathore, Ph.D., Scientific Review
Officer, Scientific Review Program, Division of Extramural
Activities, Room 3G30, National Institutes of Health/NIAID, 5601
Fishers Lane, Drive, MSC 9823, Bethesda, MD 20892-9823, 240-669-
5058, [email protected].
(Catalogue of Federal Domestic Assistance Program Nos. 93.855,
Allergy, Immunology, and Transplantation Research; 93.856,
Microbiology and Infectious Diseases Research, National Institutes
of Health, HHS)
[[Page 61768]]
Dated: December 22, 2017.
Sylvia L. Neal,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2017-28156 Filed 12-28-17; 8:45 am]
BILLING CODE 4140-01-P
